The Atlantic Coast Sexually Transmitted Infection Cooperative Research Center (AC
大西洋海岸性传播感染合作研究中心(AC
基本信息
- 批准号:8769562
- 负责人:
- 金额:$ 123.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-01 至 2019-07-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAdherenceAffectAnimal ModelAntibiotic ResistanceAntibioticsAntigen-Presenting CellsAntigenic VariationAntigensAreaBacteriaBasic ScienceBindingBiological AssayBiological MarkersBiologyCD4 Positive T LymphocytesCandyCarcinoembryonic AntigenCeftriaxoneCell WallCell physiologyCellsCenters for Disease Control and Prevention (U.S.)CephalosporinsCervix UteriChelating AgentsChlamydiaChlamydia InfectionsChlamydia trachomatisChlamydial pneumoniaClinicalClinical SciencesCommitConjunctivitisCounselingDataDendritic CellsDevelopmentDiagnosticDiseaseEcologyEctopic PregnancyEpigenetic ProcessEvolutionFailure to ThriveFrequenciesGeneticGenital systemGenitourinary systemGoalsGonorrheaHIVHealthHistone Deacetylase InhibitorHumanImmuneImmune responseImmune systemImmunityImmunobiologyImmunosuppressionImmunosuppressive AgentsImmunotherapyIn VitroIncidenceIndividualInfectionInfertilityInflammationIntegration Host FactorsInterventionIronKnowledgeLeadLife StyleLow Birth Weight InfantMeasuresMediatingMembraneMicroscopyModelingMothersMusMutationNeisseria gonorrhoeaeNeonatalNutritional SupportOrganismPathogenesisPathway interactionsPelvic Inflammatory DiseasePeptidoglycanPersonal SatisfactionPredispositionPremature Rupture Fetal MembranesPrevalencePrevention strategyPreventiveProteomePublic HealthReportingReproductive HealthResearchResearch PersonnelResistanceRiskRoleSafe SexSexual PartnersSexually Transmitted DiseasesSignal TransductionSystemT-LymphocyteTestingTherapeuticTransferrinTransgenic MiceTranslational ResearchUrethraVaccinesVaginaVesicleVisionWomanWomen&aposs HealthWorkadaptive immunitybasechronic pelvic paindesigndisorder preventioneffective therapyexperienceextracellularfitnessgonorrhea vaccineimprovedin vivoinnovationlymphocyte proliferationmeetingsmicrobialmouse modelneonatenovelpathogenperforin 2product developmentprototypepublic health relevancereceptor vaccinereproductive hormoneresistant strainresponsetissue culturetooltransmission processtreatment strategyvaccine efficacyvaccine evaluation
项目摘要
DESCRIPTION (provided by applicant): The proposed Atlantic Coast (AC) STI CRC is a highly integrated, multidisciplined alliance of experienced investigators who are committed to advancing basic and translational science in the area of Neisseria gonorrhoeae (Ng), Chlamydia trachomatis (Ct) and Ng/Ct infections that will further our understanding of the pathogenesis of these sexually transmitted infections and lead to the development of new interventions. To meet these goals, we will address the following four programmatic specific aims. Aim 1 is to define the immunobiology of Ng and Ng/Ct co-infection with respect to mechanisms of Ng-mediated immunosuppression and the mechanisms by which Ng and Ct evade or interact with effectors of the innate defense. Two novel Ng immunosuppressive pathways that interfere with dendritic cell (DC) function will be characterized. The hypothesis that these Ng pathways affect host responses to Chlamydia will also be tested. A vaginal proteome analysis will be performed using mouse models of single and dual infection to identify novel effectors that may limit or enhance infection and to assess the influence of reproductive hormones on the expression of host factors. We will also investigate the role of perforin-2, a membrane-bound pore-forming effector, in the intracellular biology of Ng, Ct and Ng/Chlamydia at the cellular level and during experimental murine infection. Aim 2 is to develop tissue culture systems, improved animal models, and immunological systems for studying Ng/Ct confection and to accelerate product development. Tissue culture systems designed to promote Ng invasion through two distinct pathways and sophisticated microscopy will be utilized to examine the intracellular biology of Ng/Ct coinfected cells. Improved mouse models will be established using human transferrin-supplemented mice that are transgenic for the human carcinoembryonic antigen-related cellular adherence molecule (hCEACAM-1); these models will be used to identify potential biomarkers that can discriminate single and dual infections. To facilitate studies on the immunobiology of co-infection, in vitro, ex vivo and in vivo assays will be developed to examine the effect of Ng on
DC-directed anti-Cm responses. Aim 3 is to understand the genetic basis of the spread of antibiotic resistant gonorrhea. The effect of ceftriaxone resistance determinants on microbial fitness in vitro and in vivo will be tested and compensatory mutations that restore fitness will be
identified. Aim 4 is to develop a gonorrhea vaccine and novel therapies effective against both gonorrhea and Chlamydia infections. A promising Ng Tf receptor vaccine will be developed and the effect of a pre-existing Chlamydia infection on the efficacy of this vaccine will be assessed. Iron-chelators will be tested as a nutritional therapy and a prototype histone deacetylase inhibitor will be tested as a potentially effective epigenetic therapy that induces the expression f innate effectors and suppresses pathogen-induced inflammation.
描述(申请人提供):拟议的大西洋海岸(AC)STI CRC是一个高度整合的多学科联盟,由经验丰富的研究人员组成,他们致力于推进淋病奈瑟菌(Ng),沙眼衣原体(Ct)和Ng/Ct感染领域的基础和转化科学,这将进一步加深我们对这些性传播感染发病机制的理解,并导致新干预措施的开发。 为了实现这些目标,我们将致力于以下四个具体的方案目标。 目的1是定义Ng和Ng/Ct共感染的免疫生物学,关于Ng介导的免疫抑制机制以及Ng和Ct逃避或与先天防御效应子相互作用的机制。 两个新的Ng免疫抑制途径,干扰树突状细胞(DC)的功能将被表征。 这些Ng途径影响宿主对衣原体的反应的假设也将被测试。 将使用单次和双重感染的小鼠模型进行阴道蛋白质组分析,以鉴定可能限制或增强感染的新型效应物,并评估生殖激素对宿主因子表达的影响。 我们还将研究穿孔素-2,膜结合的孔形成效应,在细胞水平和实验小鼠感染期间的细胞内生物学的Ng,Ct和Ng/衣原体的作用。 目标2是开发组织培养系统、改进的动物模型和免疫系统来研究Ng/Ct甜点并加速产品开发。组织培养系统,旨在促进通过两个不同的途径和先进的显微镜Ng入侵将被用来检查Ng/Ct共感染细胞的细胞内生物学。将使用人转铁蛋白补充小鼠建立改进的小鼠模型,这些小鼠是人癌胚抗原相关细胞粘附分子(hCEACAM-1)的转基因小鼠;这些模型将用于鉴定可以区分单一和双重感染的潜在生物标志物。 为了促进对共感染的免疫生物学的研究,将开发体外、离体和体内测定以检查Ng对免疫细胞的影响。
DC定向抗Cm应答。 目的3是了解耐药淋病传播的遗传基础。 将测试头孢曲松耐药决定因素对体外和体内微生物适合度的影响,并将研究恢复适合度的补偿突变。
鉴定 目标4是开发一种淋病疫苗和新的治疗方法,有效地防止淋病和衣原体感染。 将开发一种有前途的Ng Tf受体疫苗,并评估预先存在的衣原体感染对该疫苗效力的影响。铁螯合剂将作为营养疗法进行测试,原型组蛋白脱乙酰酶抑制剂将作为潜在有效的表观遗传疗法进行测试,其诱导先天效应物的表达并抑制病原体诱导的炎症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ann E. Jerse其他文献
Gonococcal PorB: a multifaceted modulator of host immune responses
淋球菌孔蛋白B:宿主免疫反应的多面调节因子
- DOI:
10.1016/j.tim.2023.10.002 - 发表时间:
2024-04-01 - 期刊:
- 影响因子:14.900
- 作者:
Rebekah A. Jones;Ann E. Jerse;Christoph M. Tang - 通讯作者:
Christoph M. Tang
emNeisseria gonorrhoeae/em Coinfection during emChlamydia muridarum/em Genital Latency Does Not Modulate Murine Vaginal Bacterial Shedding
淋病奈瑟菌/鼠衣原体生殖器潜伏期间的合并感染不会调节小鼠阴道细菌脱落
- DOI:
10.1128/spectrum.04500-22 - 发表时间:
2023-05-18 - 期刊:
- 影响因子:3.800
- 作者:
Delia Onorini;Cory Ann Leonard;Regenia Phillips Campbell;Barbara Prähauser;Theresa Pesch;Robert V. Schoborg;Ann E. Jerse;Bernadetta Tarigan;Nicole Borel - 通讯作者:
Nicole Borel
Ann E. Jerse的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ann E. Jerse', 18)}}的其他基金
The Gonorrhea Vaccine Cooperative Research Center
淋病疫苗合作研究中心
- 批准号:
10362587 - 财政年份:2019
- 资助金额:
$ 123.1万 - 项目类别:
The Gonorrhea Vaccine Cooperative Research Center
淋病疫苗合作研究中心
- 批准号:
10588233 - 财政年份:2019
- 资助金额:
$ 123.1万 - 项目类别:
Continuing Preclinical Development of PPCM Vaginal Contraceptive MPT to IND
PPCM 阴道避孕药 MPT 至 IND 的持续临床前开发
- 批准号:
9889971 - 财政年份:2017
- 资助金额:
$ 123.1万 - 项目类别:
The Atlantic Coast Sexually Transmitted Infection Cooperative Research Center (AC
大西洋海岸性传播感染合作研究中心(AC
- 批准号:
9316484 - 财政年份:2014
- 资助金额:
$ 123.1万 - 项目类别:
2014 International Pathogenic Neisseria Conference
2014年国际致病性奈瑟菌会议
- 批准号:
8785926 - 财政年份:2014
- 资助金额:
$ 123.1万 - 项目类别:
相似海外基金
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 123.1万 - 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
- 批准号:
10738120 - 财政年份:2023
- 资助金额:
$ 123.1万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10526768 - 财政年份:2022
- 资助金额:
$ 123.1万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10701072 - 财政年份:2022
- 资助金额:
$ 123.1万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10679092 - 财政年份:2021
- 资助金额:
$ 123.1万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10432133 - 财政年份:2021
- 资助金额:
$ 123.1万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10327065 - 财政年份:2021
- 资助金额:
$ 123.1万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10377366 - 财政年份:2019
- 资助金额:
$ 123.1万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10574496 - 财政年份:2019
- 资助金额:
$ 123.1万 - 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
- 批准号:
9403567 - 财政年份:2017
- 资助金额:
$ 123.1万 - 项目类别:














{{item.name}}会员




